1. Home
  2. NSPR vs AIOS Comparison

NSPR vs AIOS Comparison

Compare NSPR & AIOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.73

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

AIOS

AIOS Tech Inc. Class A Common Shares

N/A

Current Price

$8.23

Market Cap

39.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
AIOS
Founded
2005
2005
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
38.9M
39.5M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
NSPR
AIOS
Price
$0.73
$8.23
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $3.33
N/A
AVG Volume (30 Days)
★ 336.1K
6.7K
Earning Date
11-12-2026
09-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $2,310,000.00
N/A
Revenue This Year
$9.14
N/A
Revenue Next Year
$105.44
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.43
$0.39
52 Week High
$2.22
$33.87

Technical Indicators

Market Signals
Indicator
NSPR
AIOS
Relative Strength Index (RSI) 59.13 31.49
Support Level $0.66 $0.43
Resistance Level $0.77 $16.33
Average True Range (ATR) 0.10 0.64
MACD 0.04 -0.01
Stochastic Oscillator 74.86 15.26

Price Performance

Historical Comparison
NSPR
AIOS

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About AIOS AIOS Tech Inc. Class A Common Shares

AIOS Tech Inc is a provider of artificial intelligence and technology-driven professional services. The Company is focused on delivering information technology solutions, data services, and artificial intelligence-powered offerings to a diverse commercial client base. Its core businesses include digital transformation services, tailored IT solutions for the financial sector, enterprise data solutions, and the development of AI platforms and infrastructure to drive efficiency and growth for clients across multiple industries.

Share on Social Networks: